By Mill Chart
Last update: Apr 24, 2024
Which stocks are experiencing notable movement on Wednesday?
Ticker | Change | Comment |
---|---|---|
CDTX | 2.0K% | CIDARA THERAPEUTICS INC (NASDAQ:CDTX) experienced a significant 2.0K% increase, reaching $10.85 during Wednesday's session. In the last month the stock lost 31.34%. |
CSSE | 122.0% | Investors witnessed a remarkable 122.0% rise in CHICKEN SOUP FOR THE SOUL EN's (NASDAQ:CSSE) shares, which climbed to $0.34 during Wednesday's session. Shareholders saw the stock price going 56.71% lower is the past 6 months. |
PBMWW | 57.83% | PSYENCE BIOMEDICAL LTD's (NASDAQ:PBMWW) shares rose 57.83% to $0.09 during Wednesday's session. The stock is trading 44.39% lower than a month ago. |
LICN | 53.41% | With a 53.41% surge, LICHEN CHINA LTD- A's (NASDAQ:LICN) stock price reached $0.86 during Wednesday's session, signaling positive momentum. In the last month the stock lost 47.66%. |
WIMI | 40.41% | WIMI HOLOGRAM CLOUD INC-ADR (NASDAQ:WIMI) rose 40.41% to $1.02 during Wednesday's after hours session. In the last month the share price dropped with 23.19%. |
MULN | 38.46% | MULLEN AUTOMOTIVE INC's (NASDAQ:MULN) stock price is advancing with 38.46% to a price of $3.78. In the last month the stock lost 40.0%. |
AIRE | 33.28% | Exciting news for REALPHA TECH CORP (NASDAQ:AIRE) as its stock price surged 33.28% to $0.81 during Wednesday's session. Earlier today the company had a press release: reAlpha Tech Corp. Launches Claire, Real Estate’s First AI-powered, Zero-Commission Smart Buyer’s Agent. |
PRE | 32.17% | PRENETICS GLOBAL LTD-CL A's (NASDAQ:PRE) stock price displayed strong growth, advancing 32.17% and reaching $6.04 during Wednesday's session. In the last year the stock lost 63.15%. |
RBBN | 30.28% | RIBBON COMMUNICATIONS INC's (NASDAQ:RBBN) stock price is advancing with 30.28% to a price of $3.35. The company's earnings where released Yesterday. Shareholders saw the stock price going 23.56% higher is the past 6 months. |
RCAT | 29.17% | RED CAT HOLDINGS INC (NASDAQ:RCAT) witnessed a notable 29.17% uptick in its shares, reaching $1.55 during Wednesday's session. Shareholders saw the stock price going 54.7% higher in the past month. |
For the full top gainers list go to our top gainers page.
CIDARA THERAPEUTICS INC
NASDAQ:CDTX (5/17/2024, 7:00:03 PM)
11.21
-0.79 (-6.58%)
WHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cidara Therapeutics, Inc. (NASDAQ: CDTX) resulting from allegations that Cidara Therapeutics may have issued materially misleading business information to the investing public.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cidara Therapeutics (NASDAQ:CDTX) just reported results for the first quarter o...
CDTX stock results show that Cidara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
WHY: NEW YORK, NY - (NewMediaWire) - May 13, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cidara Therapeutics, Inc. (NASDAQ: CDTX) resulting from allegations that Cidara Therapeutics may have issued materially misleading business information to the investing public.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary...